Correlation Between Alphabet and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alphabet and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Dermata Therapeutics, you can compare the effects of market volatilities on Alphabet and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Dermata Therapeutics.
Diversification Opportunities for Alphabet and Dermata Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Alphabet and Dermata is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Alphabet i.e., Alphabet and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Alphabet and Dermata Therapeutics
Given the investment horizon of 90 days Alphabet Inc Class C is expected to under-perform the Dermata Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Alphabet Inc Class C is 2.78 times less risky than Dermata Therapeutics. The stock trades about -0.12 of its potential returns per unit of risk. The Dermata Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 134.00 in Dermata Therapeutics on December 29, 2024 and sell it today you would lose (16.00) from holding Dermata Therapeutics or give up 11.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Alphabet Inc Class C vs. Dermata Therapeutics
Performance |
Timeline |
Alphabet Class C |
Dermata Therapeutics |
Alphabet and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alphabet and Dermata Therapeutics
The main advantage of trading using opposite Alphabet and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.The idea behind Alphabet Inc Class C and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |